// SIGNAL

U.S.-China Tensions Shift to Lab Monkeys: Research Impacts

3 min read Signals Priority

With the shift in U.S.-China relations focusing on lab monkeys, research faces significant challenges. This shift from chip technology to biomedical necessities highlights deeper geopolitical implications.

As geopolitical dynamics between the United States and China shift increasingly towards biomedical resources, the focus has moved from semiconductors to a much less expected resource: lab monkeys. This unconventional ‘currency’ in the global research race reflects not just changing priorities but underlines a growing complexity in international scientific collaboration and competition. The implications are wide-reaching, affecting the infrastructures of biomedical research worldwide.

U.S.-China Tensions Shift to Lab Monkeys: Research Impacts

Historically, China was a major exporter of macaque monkeys, a necessity in biomedical research, to the United States. These primates are crucial for testing medicines before human trials. However, the COVID-19 pandemic introduced a seismic shift. By January 2020, China’s sudden ban on the wildlife trade, citing public health risks, dramatically decreased U.S. imports of these animals by 81.6% from China, while imports from Cambodia surged by 82.8%, with 15,664 monkeys imported in the fiscal year 2020 alone.

This strategic maneuver by China wasn’t indicative of disinterest. Rather, it underscored a refocusing of resources to meet its own booming biomedical industry needs. China’s import data supports this, showing a climb from 2,400 monkeys in 2023 to over 13,000 in 2025, with Cambodia as the leading supplier.

The Cambodian Connection

Cambodia’s emergence as a primary provider of lab monkeys has raised eyebrows, particularly given the legal and ethical questions surrounding its practices. The 2022 indictment by the U.S. Department of Justice of eight individuals accused of laundering 3,000 wild-caught macaques underscores the challenges in tracking these animals’ origin and ensuring ethical standards. It casts a shadow over the claimed capacity of Cambodian breeding programs, asking whether they can genuinely sustain such export levels without unethical practices.

These controversies have forced the U.S. to diversify sourcing strategies, looking to countries like Mauritius and Vietnam. This diversification aligns with recent U.S. policy shifts that aim to decrease reliance on animal testing, reflecting a broader scientific and ethical trend.

Scientific Shifts and Policy Changes

In response to these supply chain disruptions, the U.S. has initiated measures to reduce dependence on animal testing. Notably, in April 2025, policies were introduced under the Trump administration to remove mandatory animal testing for certain drugs, like monoclonal antibodies. Furthermore, the National Institutes of Health announced reductions in funding for animal-based research.

This trend towards minimizing animal research is not purely an ethical stance but also highlights an adaptive response to the geopolitical landscape’s realities. The discussions led by experts like Paul Nuyujukian from Stanford emphasize the need for stability in scientific processes and access to necessary research resources, suggesting a potential ‘trade war’ in research assets if both nations deem these primates a strategic limited resource.

Infrastructure Layer Detection

This geopolitical tug-of-war represents a significant shift in research infrastructure. The dependency on specific biological resources like lab monkeys when national priorities and capabilities change highlights vulnerabilities in scientific supply chains. This situation compels nations to reassess their research infrastructures, potentially spurring innovations in biological research methods or alternatives to primate testing.

As these tensions unfold, the global scientific community faces a challenge: ensuring continuity and ethics in research while geopolitical forces dictate resource availability. Nations may increasingly turn to automation and AI-driven alternatives, reshaping the methodology of scientific inquiry.

Observation recorded.